Want to join the conversation?
Healthcare diagnostics company $LH said that VENTANA PD-L1 Assay, a new immunotherapy treatment for patients with urothelial cancer, a form of bladder cancer, is available in the US. The test was developed by Roche Diagnostics and was approved on May 18, 2016 by the FDA to identify patients who could benefit from treatment with $NDA's TECENTRIQ.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.